Scheinin M - Search Results

1

Involvement of the first transmembrane segment of human α(2) -adrenoceptors in the subtype-selective binding of chlorpromazine, spiperone and spiroxatrine.

Laurila JM, Wissel G, Xhaard H, Ruuskanen JO, Johnson MS, Scheinin M. Laurila JM, et al. Among authors: scheinin m. Br J Pharmacol. 2011 Nov;164(5):1558-72. doi: 10.1111/j.1476-5381.2011.01520.x. Br J Pharmacol. 2011. PMID: 21649638 Free PMC article.

2

Characterization of [3H]atipamezole as a radioligand for alpha 2-adrenoceptors.

Sjöholm B, Voutilainen R, Luomala K, Savola JM, Scheinin M. Sjöholm B, et al. Among authors: scheinin m. Eur J Pharmacol. 1992 Apr 29;215(1):109-17. doi: 10.1016/0014-2999(92)90615-b. Eur J Pharmacol. 1992. PMID: 1355439

3

Rapid reversal of alpha 2-adrenoceptor agonist effects by atipamezole in human volunteers.

Karhuvaara S, Kallio A, Salonen M, Tuominen J, Scheinin M. Karhuvaara S, et al. Among authors: scheinin m. Br J Clin Pharmacol. 1991 Feb;31(2):160-5. doi: 10.1111/j.1365-2125.1991.tb05505.x. Br J Clin Pharmacol. 1991. PMID: 1675577 Free PMC article. Clinical Trial.

4

Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist--a randomized, double-blind cross-over study in healthy male volunteers.

Karhuvaara S, Kallio A, Scheinin M, Anttila M, Salonen JS, Scheinin H. Karhuvaara S, et al. Among authors: scheinin m, scheinin h. Br J Clin Pharmacol. 1990 Jul;30(1):97-106. doi: 10.1111/j.1365-2125.1990.tb03748.x. Br J Clin Pharmacol. 1990. PMID: 1975199 Free PMC article. Clinical Trial.

5

Sedative and cardiovascular effects of medetomidine, a novel selective alpha 2-adrenoceptor agonist, in healthy volunteers.

Scheinin M, Kallio A, Koulu M, Viikari J, Scheinin H. Scheinin M, et al. Among authors: scheinin h. Br J Clin Pharmacol. 1987 Oct;24(4):443-51. doi: 10.1111/j.1365-2125.1987.tb03196.x. Br J Clin Pharmacol. 1987. PMID: 2891369 Free PMC article. Clinical Trial.

6

Cloning and expression of a fish alpha 2-adrenoceptor.

Svensson SP, Bailey TJ, Pepperl DJ, Grundström N, Ala-Uotila S, Scheinin M, Karlsson JO, Regan JW. Svensson SP, et al. Among authors: scheinin m. Br J Pharmacol. 1993 Sep;110(1):54-60. doi: 10.1111/j.1476-5381.1993.tb13771.x. Br J Pharmacol. 1993. PMID: 7693288 Free PMC article.

7

Use of recombinant human alpha 2-adrenoceptors to characterize subtype selectively of antagonist binding.

Marjamäki A, Luomala K, Ala-Uotila S, Scheinin M. Marjamäki A, et al. Among authors: scheinin m. Eur J Pharmacol. 1993 Aug 15;246(3):219-26. doi: 10.1016/0922-4106(93)90034-7. Eur J Pharmacol. 1993. PMID: 7901041

8

Coupling of human alpha 2-adrenoceptor subtypes to regulation of cAMP production in transfected S115 cells.

Jansson CC, Marjamäki A, Luomala K, Savola JM, Scheinin M, Akerman KE. Jansson CC, et al. Among authors: scheinin m. Eur J Pharmacol. 1994 Jan 15;266(2):165-74. doi: 10.1016/0922-4106(94)90106-6. Eur J Pharmacol. 1994. PMID: 7908883

9

Marjamäki A, Pohjanoksa K, Ala-Uotila S, Sizmann D, Oker-Blom C, Kurose H, Scheinin M. Marjamäki A, et al. Among authors: scheinin m. Eur J Pharmacol. 1994 Mar 15;267(1):117-21. doi: 10.1016/0922-4106(94)90232-1. Eur J Pharmacol. 1994. PMID: 7911432

10

Reduced turnover of dopamine and 5-hydroxytryptamine in discrete dopaminergic, noradrenergic and serotonergic rat brain areas after acutely administered medetomidine, a selective alpha 2-adrenoceptor agonist.

Koulu M, Pesonen U, Koskinen S, Scheinin H, Virtanen R, Scheinin M. Koulu M, et al. Among authors: scheinin m, scheinin h. Pharmacol Toxicol. 1993 Mar;72(3):182-7. doi: 10.1111/j.1600-0773.1993.tb00313.x. Pharmacol Toxicol. 1993. PMID: 8100065

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

389 results

Search Page

Filters